Testing effectiveness (Phase 2)Study completedNCT01803035What this trial is testingA Phase II Study to Evaluate the Efficacy and Safety of Two Doses of LTX-109 in ImpetigoWho this might be right forNon-bullous Impetigo Lytix Biopharma AS 210